Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
(2001). Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist. J Hypertens Suppl.
(2001). Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension. J Hum Hypertens.
(2009). Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: Post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig.
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
(2010). Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension. J Hum Hypertens.
(2009). Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: A randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig.
(2007). Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
(2005). Impact of medication adherence on hospitalization risk and healthcare cost. Med Care.
(2003). Incidence of pedal edema formation with dihydropyridine calcium channel blockers: Issues and practical significance. J Clin Hypertens
(2008). Olmesartan for the treatment of arterial hypertension. Future Cardiol.
(2009). Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderateto-severe hypertension after monotherapy: A randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig.
Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document.
Relation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapy.
Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: Evaluation by baseline hypertension stage and prior antihypertensive medication use.
(2008). The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebocontrolled, 8-week factorial efficacy and safety study. Clin Ther.
Vasodilatory edema: A common side effect of antihypertensive therapy.